- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03458988
Blood-pressure Measuring in Patients Carrying a Left Ventricular Assist Device (LVAD)
Pilot Study to Validate a Novel Blood-pressure Measuring Device in Patients Carrying a Left Ventricular Assist Device
To prove the novel device is able to reliably detect pulsatility in patients with CF-VADs and to analyze whether pre-programmed intrinsic pulsatility of the 3rd generation CF-VADs can also be picked up. The study is not designed to measure blood pressure.
Should this pilot study be successful in detecting enough pulsatility a follow-up study would then try to transfer the results into blood-pressure values with the help of comparators in order to identify an easier and more reliable method to measure BP in CF-VAD patients. .
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The number of patients supported by left ventricular assist device (LVAD) is increasing as durable mechanical support has become widely available for end stage heart failure as destination therapy and as bridge to transplantation. The accurate measurement of blood pressure (BP) as well as the recognition and management of hypertension in patients with LVADs is an essential component of optimal clinical care. Hypertension is an established long-term risk factor for cardiovascular disease. The measurement of BP and the management of hypertension in patients with CF-VADs can present unique challenges. Patients with LVADs often do not have a palpable pulse, and therefore traditional BP measurement by auscultation or automated cuff is less reliable. Conventional occlusive BP measurement is able to to pick up signals in approximately 50% of cases due to coincidental phases of pulsatility. The arterial line is the gold standard, but is an invasive procedure and not practical for routine outpatient use.
Although efforts are underway to identify an easier and more reliable method to measure ambulatory BP in these patients not one has been able to match the quality of an invasive arterial line.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bern, Switzerland, 3010
- University Hospital Bern
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients carrying one of the two third generation CF-VADS (Heartware HVAD, Heartmate 3)
- Patients >18y
- Good understanding of written and oral German
- Signed informed consent
- Scheduled for routine outpatient appointment.
Exclusion Criteria:
- In the population of the outpatient clinic's CV-LVAD patients no known exclusion criteria exists
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: All patients
Nellcor™ Adult SpO2 Sensor
|
Data will be acquired for 10 minutes with a reusable off the shelf adult SpO2 sensor.
The Nellcor™ Adult SpO2 Sensor, model DS-100A, is indicated for use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for patients weighing greater than 40 kg.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
RR (Riva Rocci, indirect blood pressure measurement) in LVAD
Time Frame: 10 min blood measuring
|
Detect pulsatility in CF-VAD (Continuous flow- ventricular assist device) patients sufficient to calculate comprehensible blood-pressure values in future follow-up studies
|
10 min blood measuring
|
Collaborators and Investigators
Investigators
- Principal Investigator: David Reineke, MD, University Hospial Bern, Cardio Vascular Surgery
Publications and helpful links
General Publications
- Saeed O, Jermyn R, Kargoli F, Madan S, Mannem S, Gunda S, Nucci C, Farooqui S, Hassan S, Mclarty A, Bloom M, Zolty R, Shin J, D'Alessandro D, Goldstein DJ, Patel SR. Blood pressure and adverse events during continuous flow left ventricular assist device support. Circ Heart Fail. 2015 May;8(3):551-6. doi: 10.1161/CIRCHEARTFAILURE.114.002000. Epub 2015 Apr 13.
- Lampert BC, Eckert C, Weaver S, Scanlon A, Lockard K, Allen C, Kunz N, Bermudez C, Bhama JK, Shullo MA, Kormos RL, Dew MA, Teuteberg JJ. Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events. Ann Thorac Surg. 2014 Jan;97(1):139-46. doi: 10.1016/j.athoracsur.2013.07.069. Epub 2013 Sep 25.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2017-01570
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Left Ventricular Assist Device
-
Abbott Medical DevicesThoratec Europe LtdCompletedAnticoagulation | Left Ventricular Assist DeviceUnited States, Austria, France, Germany, Czechia
-
National Taiwan University HospitalCompletedPhysical Therapy | Left Ventricular Assist DeviceTaiwan
-
Karol WierzbickiMedtronic Poland Spółka z ograniczoną odpowiedzialnością; Cor Aegrum Foundation... and other collaboratorsCompletedLeft Ventricular Assist DevicePoland
-
Abbott Medical DevicesThoratec CorporationCompletedLeft Ventricular Assist Device | Percutaneous Lead ManagementUnited States
-
University of California, DavisUniversity of California, San DiegoRecruitingLVAD (Left Ventricular Assist Device) Driveline InfectionUnited States
-
University of California, San FranciscoInternational Consortium of Circulatory Assist CliniciansRecruitingLVAD (Left Ventricular Assist Device) Driveline InfectionUnited States
-
Supira MedicalNot yet recruitingVentricular Assist Device
-
Rigshospitalet, DenmarkRecruitingHeart Failure | Prognosis | Left Ventricular Assist Device | Durable Mechanical Support DeviceDenmark
-
Cardiora Pty. Ltd.CompletedRight Heart Failure | Left Ventricular Assist DeviceUnited States
-
Mayo ClinicWithdrawnHeart Failure | Left Ventricular Assist Device | Natriuretic Peptide